Company news
Solasia Pharma Kk (TSE:4597) news
Solasia Pharma Kk news releases on 6ix. Latest, Aug 13, 2026: Consolidated Financial Results for the Six Months Ended June 30, 2026 (Under IFRS)
Press releases & updates
Consolidated Financial Results for the Six Months Ended June 30, 2026 (Under IFRS)
August 13, 2026
Solasia Announces Launch of Darvias® in Japan
August 22, 2022
Solasia Pharma K K : Consolidated Financial Results for the First Six Months of the Fiscal Year Ending December 31, 2022 (under IFRS)
August 15, 2022
Solasia Pharma K K : Announces Topline Data from Phase III AGENT Study of SP-05(arfolitixorin)
August 3, 2022
Solasia Pharma K K : Announces Capital and Business Alliance with Nippon Kayaku Co., Ltd.
June 28, 2022
Solasia Pharma: DARVIAS® Injection 135mg (Generic Name: DARINAPARSIN /Development Code: SP-02) Approved in Japan
June 19, 2022
Solasia Pharma K K : Announces Finance via Issuance of Unsecured Straight Bond and Warrant
February 14, 2022
Consolidated Financial Results for the Nine Months of the Fiscal Year Ending December 31, 2021 (under IFRS)
November 10, 2021
Solasia Announces Revision to Full-Year Earnings Forecast
November 10, 2021
Solasia Pharma K K : Consolidated Financial Results for the First Six Months of the Fiscal Year Ending December 31, 2021 (under IFRS)
August 11, 2021
Solasia Pharma K K : Solasia Announces Submission of New Drug Application for Anti-cancer Drug DARINAPARSIN for Peripheral T-Cell Lymphoma in Japan
June 30, 2021
Solasia Pharma K K : Announces Submission of New Drug Application for Anti-cancer Drug DARINAPARSIN for Peripheral T-Cell Lymphoma in Japan
June 30, 2021
Solasia Pharma K K : Announces Exercise Price Revisions Associated with Series 12 Warrants
June 30, 2021
Solasia Pharma K K : Announces episil was Recommended in Guidelines for Oral Mucositis Caused by Anti-tumor Therapy by CSCO
May 31, 2021
Solasia Pharma K K : Announces Completion of Exercise of Series 11 Warrants
May 14, 2021
Solasia Pharma K K : Consolidated Financial Results for the First Three Months of the Fiscal Year Ending December 31, 2021 (under IFRS)
May 12, 2021